XOMA Capex To Revenue from 2010 to 2024
| XOMAO Preferred Stock | USD 25.39 0.03 0.12% |
Check XOMA financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among XOMA's main balance sheet or income statement drivers, such as , as well as many indicators such as . XOMA financial statements analysis is a perfect complement when working with XOMA Valuation or Volatility modules.
XOMA |
About XOMA Financial Statements
XOMA investors utilize fundamental indicators, such as Capex To Revenue, to predict how XOMA Preferred Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California. Xoma Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 12 people.
Pair Trading with XOMA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if XOMA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XOMA will appreciate offsetting losses from the drop in the long position's value.Moving against XOMA Preferred Stock
| 0.83 | FNCH | Finch Therapeutics | PairCorr |
| 0.74 | HRGN | Harvard Apparatus | PairCorr |
| 0.72 | CEROW | CERo Therapeutics Symbol Change | PairCorr |
| 0.67 | ENSCW | Ensysce Biosciences | PairCorr |
| 0.62 | CYCCP | Cyclacel Pharmaceuticals | PairCorr |
The ability to find closely correlated positions to XOMA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace XOMA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back XOMA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling XOMA Corporation to buy it.
The correlation of XOMA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as XOMA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if XOMA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for XOMA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in XOMA Preferred Stock
XOMA financial ratios help investors to determine whether XOMA Preferred Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in XOMA with respect to the benefits of owning XOMA security.